ZWZhilian Wang

Zhilian Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhilian Wang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Feng

    Department of Obstetrics and Gynecology Second Hospital of Shanxi Medical University Taiyuan China

    1 shared publication
  • Chenyao Guo

    Department of Obstetrics and Gynecology Second Hospital of Shanxi Medical University Taiyuan China

    1 shared publication
  • Dongyan Li

    Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, China

    1 shared publication
  • Hui-Qiang Liu

    Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, China

    1 shared publication
  • Jing Li

    Department of Obstetrics and Gynecology Second Hospital of Shanxi Medical University Taiyuan China

    1 shared publication
  • Jing Yang

    Peking Univ Third Hosp, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing, Peoples R China

    1 shared publication

Latest Publications

  • Open Access

    Focusing on VaIN2 +: Development and validation of a prediction nomogram based on a large colposcopy population

    by Quanlong Lu, Yao Liu, Jing Li, Chenyao Guo, Ruifang Li, Bo Feng, Xun Gao, Lifang Gao, Zhilian Wang

    Introduction: Vaginal intraepithelial neoplasia 2 or worse (VaIN2+) has long remained in a largely passive diagnostic pattern due to the lack of specific clinical manifestations and routine screening strategies. This study aimed to explore its clinical characteristics and develop a prediction model for individualized risk assessment. Material and Methods: We retrospectively analyzed the clinical characteristics and human papillomavirus (HPV) genotype distribution in 3259 women undergoing colposcopy at a single center between September 2012 and December 2024. A nomogram was developed based on predictors initially screened by least absolute shrinkage and selection operator regression and finalized through multivariable logistic regression. The model's discriminative ability, calibration, and clinical utility were assessed in both training and validation sets. Results: Among 1192 women with VaIN2+, older age, HPV infection, cytology worse than atypical squamous cells of undetermined significance (ASCUS), and concurrent cervical/vulvar lesions were more prevalent than in 2067 women without vaginal lesions. HPV16, HPV58, HPV52, HPV33, and HPV18 were the most common genotypes. A nomogram was developed based on 10 independent predictors identified by multivariable analysis, including age, hysterectomy history, specific HPV genotypes (16, 58, 56, 35, 39), cytological results (ASCUS and worse), concurrent cervical lesions (cervical intraepithelial neoplasia 1, cervical intraepithelial neoplasia 2 or 3, cervical squamous cell carcinoma), and concurrent vulvar lesions. The nomogram demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.771 in the training set and 0.791 in the validation set. Calibration was satisfactory, and decision curve analysis confirmed superior clinical net benefit across a wide threshold probability range. Conclusions: By profiling VaIN2+ characteristics, this study developed the first prediction model integrating specific HPV genotypes with multiple clinical factors. This model enables clinicians to proactively identify high‐risk individuals, thereby facilitating earlier diagnosis and intervention for VaIN2+.

  • Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women

    by Jing Yang, Wei Wang, Zhe Wang, Zhilian Wang, Yonghong Wang, Jintao Wang, Weihong Zhao, Dongyan Li, Huiqiang Liu, Min Hao

    Human papillomavirus(HPV) infection is a necessary factor for the development of cervical cancer. The HPV vaccine is currently available, but there is still a lack of large-scale research on the distribution and risk factors of HPV. The aim of this study is to investigate the genotype distribution and risk factors of HPV infection in Yangqu which is located in North China. This study enrolled 10086 women aged <65 years from Yangqu County. HPV genotypes were identified via standard HPV DNA testing. The overall prevalence of HPV infection was 8.92%. The prevalence of high-risk HPV types was 8.80%, and it was 0.38% for low-risk HPV types. Single genotype infection accounted for 67.91% in HPV-positive cases. The most common HPV genotypes were HPV-16, −52, and −58. HPV-18 was only the 11th most common type in HPV-positive cases. Women ≥50 years of age had the highest prevalence rate of HPV, and women <30 years had the lowest prevalence rate. The distribution of HPV genotypes also varied among the three age groups: <30, 30–49, and ≥50 years. The risk factors that contributed to the rate of HPV infection included low educational level, low income, smoking, age at first sexual encounter <23 years old, and number of births ≥3 times. This large routine clinical practice report of HPV prevalence and genotype distribution revealed the characteristics of HPV infection-type distributions in Shanxi Province, which should be considered in formulating comprehensive prevention strategies including vaccination for cervical cancer in China.